Evidence map›Paper›PMID 36193934›Full record

ArticleJournal of the American Heart Association2022

Lipidome- and Genome-Wide Study to Understand Sex Differences in Circulatory Lipids.

Rubina Tabassum, Sanni Ruotsalainen, Linda Ottensmann, Mathias J Gerl, Christian Klose, Taru Tukiainen, Matti Pirinen, Kai Simons, Elisabeth Widén, Samuli Ripatti

Open access · goldAbstract read
In one paragraph

Article in Journal of the American Heart Association, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 1 pooled it
8.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 1 synthesis or guideline pooled it, 65 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. A sex-specific genome-wide association study of blood lipid levels in All of Us.medRxiv : the preprint server for health sciences · 2025
    Article
  19. Article
  20. Ceramide as a Biomarker for HFpEF in Women: Menopause, Aging, and Pregnancy.International journal of molecular sciences · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Rubina TabassumInstitute for Molecular Medicine Finland, HiLIFE University of Helsinki Finland.ORCID 0000-0002-3120-3041
Sanni RuotsalainenInstitute for Molecular Medicine Finland, HiLIFE University of Helsinki Finland.
Linda OttensmannInstitute for Molecular Medicine Finland, HiLIFE University of Helsinki Finland.ORCID 0000-0002-0096-8308
Mathias J GerlLipotype GmbH Dresden Germany.ORCID 0000-0002-8074-7221
Christian KloseLipotype GmbH Dresden Germany.ORCID 0000-0003-2853-4533
Taru TukiainenInstitute for Molecular Medicine Finland, HiLIFE University of Helsinki Finland.ORCID 0000-0002-5404-8398
Matti PirinenInstitute for Molecular Medicine Finland, HiLIFE University of Helsinki Finland.ORCID 0000-0002-1664-1350
Kai SimonsLipotype GmbH Dresden Germany.
Elisabeth WidénInstitute for Molecular Medicine Finland, HiLIFE University of Helsinki Finland.ORCID 0000-0001-7108-2806
Samuli RipattiInstitute for Molecular Medicine Finland, HiLIFE University of Helsinki Finland.ORCID 0000-0002-0504-1202
University of Helsinki · FIBroad Institute · USGenotype (Germany) · DEStatistics Finland · FI

Funding

Medical Research Council MC_PC_17228Medical Research Council MC_QA137853
6 · The paper itself

Abstract

Background Despite well-recognized differences in the atherosclerotic cardiovascular disease risk between men and women, sex differences in risk factors and sex-specific mechanisms in the pathophysiology of atherosclerotic cardiovascular disease remain poorly understood. Lipid metabolism plays a central role in the development of atherosclerotic cardiovascular disease. Understanding sex differences in lipids and their genetic determinants could provide mechanistic insights into sex differences in atherosclerotic cardiovascular disease and aid in precise risk assessment. Herein, we examined sex differences in plasma lipidome and heterogeneity in genetic influences on lipidome in men and women through sex-stratified genome-wide association analyses. Methods and Results We used data consisting of 179 lipid species measured by shotgun lipidomics in 7266 individuals from the Finnish GeneRISK cohort and sought for replication using independent data from 2045 participants. Significant sex differences in the levels of 141 lipid species were observed (

Indexed as

Cardiovascular DiseasesLipidomicsCeramidesCholesterol EstersFemaleGenome-Wide Association StudyGlyceridesHumansLipidsLysophospholipidsMaleMiddle AgedSex CharacteristicsCeramidesCholesterol EstersGlyceridesLipidsLysophospholipidslipidomesex differencessex‐stratified genome‐wide association study

Identifiers

PMID36193934
PMCPMC9673737
OpenAlexW4301391759

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.